David Grimaldi
Overview
Explore the profile of David Grimaldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
1767
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Serck N, Piagnerelli M, Augy J, Annoni F, Ottavy G, Courcelle R, et al.
BMC Anesthesiol
. 2023 Apr;
23(1):138.
PMID: 37106345
Background: Despite evidence suggesting a higher risk of barotrauma during COVID-19-related acute respiratory distress syndrome (ARDS) compared to ARDS due to other causes, data are limited about possible associations with...
12.
Toffart A, Meert A, Wallet F, Gibelin A, Guisset O, Gonzalez F, et al.
Ann Intensive Care
. 2023 Apr;
13(1):29.
PMID: 37072645
Background: Immune checkpoint inhibitors (ICI) have revolutionized the management of cancer. They can induce immune-related adverse events (irAE) leading to intensive care unit (ICU) admission. We aimed to describe irAEs...
13.
Trent L, Law J, Grimaldi D
Intensive Care Med
. 2023 Mar;
49(4):440-443.
PMID: 36964216
No abstract available.
14.
Hariri G, Genoud M, Bruckert V, Chosidow S, Guerot E, Kimmoun A, et al.
Crit Care
. 2023 Jan;
27(1):6.
PMID: 36609390
Objectives: The occurrence of mediastinitis after cardiac surgery remains a rare and severe complication associated with poor outcomes. Whereas bacterial mediastinitis have been largely described, little is known about their...
15.
Peju E, Belicard F, Silva S, Hraiech S, Painvin B, Kamel T, et al.
Intensive Care Med
. 2022 Aug;
48(9):1185-1196.
PMID: 35978137
Purpose: Management and outcomes of pregnant women with coronavirus disease 2019 (COVID-19) admitted to intensive care unit (ICU) remain to be investigated. Methods: A retrospective multicenter study conducted in 32...
16.
Karakike E, Scicluna B, Roumpoutsou M, Mitrou I, Karampela N, Karageorgos A, et al.
Crit Care
. 2022 Jun;
26(1):183.
PMID: 35717241
Background: Clarithromycin may act as immune-regulating treatment in sepsis and acute respiratory dysfunction syndrome. However, clinical evidence remains inconclusive. We aimed to evaluate whether clarithromycin improves 28-day mortality among patients...
17.
Albayrak N, Orte Cano C, Karimi S, Dogahe D, Van Praet A, Godefroid A, et al.
Front Immunol
. 2022 Apr;
13:769839.
PMID: 35422799
The new pandemic virus SARS-CoV-2 is characterized by uncontrolled hyper-inflammation in severe cases. As the IL-22/IL-22R1 axis was reported to be involved in inflammation during viral infections, we characterized the...
18.
Brauns E, Azouz A, Grimaldi D, Xiao H, Thomas S, Nguyen M, et al.
JCI Insight
. 2022 Apr;
7(9).
PMID: 35380990
Severe COVID-19 disease is associated with dysregulation of the myeloid compartment during acute infection. Survivors frequently experience long-lasting sequelae, but little is known about the eventual persistence of this immune...
19.
Coussement J, Zuber B, Garrigues E, Gros A, Vandueren C, Epaillard N, et al.
Chest
. 2022 Jan;
161(6):1475-1484.
PMID: 35063450
Background: The characteristics and outcomes of adult patients with respiratory syncytial virus (RSV) infection who require ICU admission are poorly defined. Although several studies in adults with RSV infection have...
20.
Axfors C, Janiaud P, Schmitt A, Vant Hooft J, Smith E, Haber N, et al.
BMC Infect Dis
. 2021 Nov;
21(1):1170.
PMID: 34800996
Background: Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of...